BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37147980)

  • 1. A review article on the dosimetry in intraluminal HDR brachytherapy of lung carcinoma.
    Kant R; Gupta M; Bisht J; Nautiyal V; Kumar V; Dobhal R; Ahmed M; Saini S
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S36-S40. PubMed ID: 37147980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison between three dimensional treatment planning system, Monte Carlo simulation and gel dosimetry in nasopharynx phantom for high dose rate brachytherapy.
    Fazli Z; Sadeghi M; Zahmatkesh MH; Mahdavi SR; Tenreiro C
    J Cancer Res Ther; 2013; 9(3):402-9. PubMed ID: 24125974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric impact of an air passage on intraluminal brachytherapy for bronchus cancer.
    Okamoto H; Wakita A; Nakamura S; Nishioka S; Aikawa A; Kato T; Abe Y; Kobayashi K; Inaba K; Murakami N; Itami J
    J Radiat Res; 2016 Nov; 57(6):637-645. PubMed ID: 27605630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the experimental validation of model-based dose calculation algorithms for
    Pappas EP; Zoros E; Moutsatsos A; Peppa V; Zourari K; Karaiskos P; Papagiannis P
    Phys Med Biol; 2017 May; 62(10):4160-4182. PubMed ID: 28353447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric verification of a high dose rate brachytherapy treatment planning system in homogeneous and heterogeneous media.
    Uniyal SC; Sharma SD; Naithani UC
    Phys Med; 2013 Mar; 29(2):171-7. PubMed ID: 22342220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.
    Anagnostopoulos G; Baltas D; Pantelis E; Papagiannis P; Sakelliou L
    Phys Med Biol; 2004 Jun; 49(12):2675-85. PubMed ID: 15272681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of microDiamond detectors for the determination of absorbed dose to water around high-dose-rate
    Kaveckyte V; Malusek A; Benmakhlouf H; Alm Carlsson G; Carlsson Tedgren Å
    Med Phys; 2018 Jan; 45(1):429-437. PubMed ID: 29171060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosimetric study of prostate brachytherapy using Monte Carlo simulations with a voxel phantom, measurements and a comparison with a treatment planning procedure.
    Teles P; Barros S; Cardoso S; Facure A; da Rosa LA; Santos M; Pereira P; Vaz P; Zankl M
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):482-7. PubMed ID: 25870437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
    Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
    Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gafchromic film dosimetry of a new HDR 192Ir brachytherapy source.
    Ayoobian N; Asl AS; Poorbaygi H; Javanshir MR
    J Appl Clin Med Phys; 2016 Mar; 17(2):194-205. PubMed ID: 27074483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characterization of round HDR 192Ir accuboost applicators for breast brachytherapy.
    Rivard MJ; Melhus CS; Wazer DE; Bricault RJ
    Med Phys; 2009 Nov; 36(11):5027-32. PubMed ID: 19994513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-to-end dosimetric audit: A novel procedure developed for Irish HDR brachytherapy centres.
    Bassi S; Berrigan L; Zuchora A; Fahy L; Moore M
    Phys Med; 2020 Dec; 80():221-229. PubMed ID: 33190078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo dosimetry of high dose rate gynecologic interstitial brachytherapy.
    Desbiens M; D'Amours M; Afsharpour H; Verhaegen F; Lavallée MC; Thibault I; Vigneault É; Beaulieu L
    Radiother Oncol; 2013 Dec; 109(3):425-9. PubMed ID: 24135700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.